Professional Seasonal Analysis for Trading

Rigel Pharmaceuticals, Inc. - Common Stock (RIGL)

Seasonality Analysis

Stocks 26 Years Analyzed

Rigel Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

13.96%
Avg Annual Return
44.7%
Avg Monthly Win Rate
7/12
Positive Months
26
Years Analyzed

Rigel Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -2.83%
38%
Very Weak
February -4.19%
31%
Very Weak
March -1.60%
50%
Weak
April 3.74%
54%
Moderate
May -0.91%
40%
Weak
June 1.39%
40%
Weak
July 0.55%
52%
Moderate
August 0.72%
36%
Weak
September 1.65%
52%
Moderate
October WORST -7.08%
36%
Very Weak
November 7.30%
54%
Moderate
December BEST 15.24%
54%
Moderate

Rigel Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
30.66
Historical Avg Position
42.65
Deviation
-11.98
Performance
Significantly Below Average

Rigel Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for RIGL with overlay patterns, custom date ranges, and more.

Create Free Account

Rigel Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Rigel Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for RIGL across multiple timeframes.

Create Free Account

About Rigel Pharmaceuticals, Inc. - Common Stock (RIGL) Seasonality

Rigel Pharmaceuticals, Inc. - Common Stock (RIGL) has been analyzed using 26 years of historical data to identify seasonal patterns. Classified under Stocks, Rigel Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Rigel Pharmaceuticals, Inc. - Common Stock is historically December, with an average return of 15.24% and a win rate of 54%. Conversely, October tends to be the weakest month, averaging -7.08% return.

Looking at the full calendar year, Rigel Pharmaceuticals, Inc. - Common Stock has an average annual return of 13.96% with an overall monthly win rate of 44.7%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for Rigel Pharmaceuticals, Inc. - Common Stock has a consistency score of 36.6 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Rigel Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Rigel Pharmaceuticals, Inc. - Common Stock (RIGL)?

Historically, December has been the best month for Rigel Pharmaceuticals, Inc. - Common Stock, with an average return of 15.24% and a win rate of 54%. However, past performance does not guarantee future results.

What is the worst month for Rigel Pharmaceuticals, Inc. - Common Stock (RIGL)?

Based on historical data, October has been the weakest month for Rigel Pharmaceuticals, Inc. - Common Stock, with an average return of -7.08%. This is a historical observation and does not guarantee future results.

How reliable is RIGL seasonality data?

The seasonality analysis for Rigel Pharmaceuticals, Inc. - Common Stock is based on 26 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Rigel Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Rigel Pharmaceuticals, Inc. - Common Stock (RIGL) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.